Skip to main content

MoneyWorks4Me

USFDA red flags Torrent Pharmaceuticals for violation of regulations at Indrad facility

18 Oct 2019 Evaluate

The United States Food and Drug Administration (USFDA) has red-flagged Torrent Pharmaceuticals for significant violations of current good manufacturing practice (CGMP) regulations at its Indrad facility in Gujarat. The US health regulator had inspected the facility from April 8 to 16, 2019.

Torrent Pharmaceuticals is Flagship Company of the Torrent group, a leader in cardiovascular and central nervous system segments. It also has presence in gastro-intestinal, diabetology, anti-infective and pain management segments.

Peers
Company Name CMP
Sun Pharma. Inds. 1778.25
Dr. Reddys Labs. 1350.20
Cipla 1380.00
Lupin 2009.00
Zydus Lifesciences 1244.00
View more..